{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:49:42Z","timestamp":1759481382614},"reference-count":12,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.2217\/imt-2018-0031","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T09:04:09Z","timestamp":1536224649000},"page":"1027-1031","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Rituximab Treatment for Immune-Complex-Mediated Membranoproliferative Glomerulonephritis"],"prefix":"10.1080","volume":"10","author":[{"given":"Qianshuo","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Peking University People\u2019s Hospital, Beijing,100044, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking University People\u2019s Hospital, Beijing,100044, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking University People\u2019s Hospital, Beijing,100044, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking University People\u2019s Hospital, Beijing,100044, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking University People\u2019s Hospital, Beijing,100044, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,9,6]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000084"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1108178"},{"key":"e_1_3_5_5_1","first-page":"973609","article-title":"CD20+ B cell depletion in systemic autoimmune diseases: common mechanism of inhibition or disease-specific effect on humoral immunity","author":"Pateinakis P","year":"2014","unstructured":"Pateinakis P , PyrpasopoulouA . CD20+ B cell depletion in systemic autoimmune diseases: common mechanism of inhibition or disease-specific effect on humoral immunity . Biomed. Res. Int.2014 , 973609 ( 2014 ).","journal-title":"Biomed. Res. Int."},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2011.10.005"},{"issue":"2","key":"e_1_3_5_7_1","first-page":"139","article-title":"KDIGO clinical practice guideline for glomerulonephritis","volume":"2","author":"Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group","year":"2012","unstructured":"Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group . KDIGO clinical practice guideline for glomerulonephritis . Kidney Int. Suppl.2 ( 2 ), 139 \u2013 274 ( 2012 ).","journal-title":"Kidney Int. Suppl."},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12206"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr236"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/039139880703000306"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2014.50.6.2141371"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.5414\/CN107299"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.09.038"},{"issue":"3","key":"e_1_3_5_14_1","first-page":"350","article-title":"Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?","volume":"20","author":"Ahmed MS","year":"2007","unstructured":"Ahmed MS , WongCF . Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?J. Nephrol.20 ( 3 ), 350 \u2013 356 ( 2007 ).","journal-title":"J. Nephrol."}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2018-0031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:27:17Z","timestamp":1715981237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2018-0031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.2217\/imt-2018-0031"],"URL":"https:\/\/doi.org\/10.2217\/imt-2018-0031","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-03-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}